Free Trial

Confidence In AZ Vaccine Remains Low In France And Germany: YouGov

EUROPE

Latest tracker polling from YouGov shows that a month after the widespread coverage of an extremely rare blood clotting issue in relation to the AstraZeneca COVID-19 vaccine, trust for the jab in Germany and France remains low. In Denmark trust has also collapsed following the gov'ts permanent halt to the vaccine's rollout there.

  • AstraZeneca: UK: 78% safe (+1 from mid-Mar), Spain: 54% (+16), Italy: 48% (+12), Sweden: 44% (+1), Germany: 34% (+2), Denmark: 25% (-17), France: 22% (-1). Fieldwork 13-22 Apr.

Public trust in Europe is uniformly higher for those vaccines that have been rolled out most in each respective country, with the Pfizer/BioNTech and Moderna vaccines scoring well in highly-vaccinated states such as Denmark, Italy and Spain:

  • Pfizer/BioNTech: Denmark: 81% safe (+5 from mid-Mar), UK: 80% safe (+1 from mid-Mar), Spain: 77% (+3), Italy: 76% (+7), Sweden: 70% (+9), Germany: 69% (+3), France: 56% (+5). Fieldwork 13-22 Apr.
  • Moderna: Spain: 72% safe (+4 from mid-Mar), Denmark: 68% (+4), Italy: 66% (+10), Sweden: 63% (+7), UK: 63% safe (+13), Germany: 57% (+2), France: 47% (+8). Fieldwork 13-22 Apr.

There is also uniformly low trust in the Russian Sputnik V vaccine, although it is somewhat higher in Italy, Spain and Germany, where their gov'ts have spoken about securing doses outside the EU's purchase scheme if/when it is approved by the EMA:

  • Sputnik V: Italy: 41% safe, Spain: 41%, Germany: 30%, Sweden: 23%, UK: 19%, France: 17%, Denmark: 12%. Fieldwork 13-22 Apr.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.